home All News open_in_new Full Article
Novo Nordisk consigue la autorización de la EMA para el uso de una de sus terapias contra la obesidad en niños
today 6 d. ago attach_file Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Culture
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Economics
attach_file
Politics
attach_file
Events
attach_file
Politics
attach_file
Politics
attach_file
Politics
ID: 1229940592